Log in
Enquire now
‌

Nexium Dyspepsia/AST

OverviewStructured DataIssuesContributors

Contents

clinicaltrials.gov/study/NCT00251992
Is a
‌
Clinical study
0

Clinical Study attributes

NCT Number
NCT002519920
Health Conditions in Trial
Gastrointestinal disease
Gastrointestinal disease
0
Trial Recruitment Size
1,2000
Trial Sponsor
AstraZeneca
AstraZeneca
0
Clinical Trial Start Date
2002
0
Primary Completion Date
2005
0
Study Completion Date
2005
0
Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Interventional Trial Phase
Phase 30
Official Name
Supportive Test for Acid-Related Symptoms (STARS II) With Esomeprazole and a Following 7-week, Double-blind, Randomized, Placebo Controlled Treatment Period in Uninvestigated Subjects With Upper Gastrointestinal Symptoms0
Last Updated
January 24, 2011
0
Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Double0
Study summary

The aim is to evaluate if the resolution of upper abdominal symptoms (pain or burning) during an acid suppressive test trial of esomprazole given daily for 7 days predicts symptoms resolution at the end of a subsequent treatment period of 7 weeks.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like Nexium Dyspepsia/AST

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.